Recent Health releases

HPV VACCINATION: Why does the door to a splendid future still remain closed?

[PRESSWIRE] Paris - September 12, 2018 -- HPV genital infections are the most frequent sexually transmitted infections of viral origin and definitely represent a global burden with significant oncogenic potential. HPV infection causes external genital warts, and some HPV types are strongly associated with cancer or precancerous lesions. HPV induced cancers are mostly (but not only!) those of the ano-genital region, such as cervical, anal, vulvar, penile cancer, etc., but the cancers of the mouth and/or throat are also included.

Dangers of tattoos – even the new ECHA proposals are not enough to guarantee safe inks!

[PRESSWIRE] Paris - September 12, 2018 -- Tattooing has gained tremendous popularity in Western countries. In Australia, Finland France and Germany, approximately 10% of the populations have at least one tattoo [1]. The ‘tattoo craze’ is particularly strong among the young generation, in which every third or fourth person has a tattoo.

ECHT-EVAL 2018 – the German project implementing the WHO ‘Global Report on Psoriasis’

[PRESSWIRE] Paris - September 12, 2018 -- Psoriasis is a chronic, non-communicable skin disease characterized by bright, silvery-white scales on reddened (inflamed) patches of skin, mainly on the arms and legs, the scalp, but also on many other areas of the body, including the genitals.

Caffeine consumption might extend life expectancy in CKD patients

[PRESSWIRE] Parma - 12 September, 2018 -- A study, which has been published in NDT [1] today shows that caffeine consumption is associated with a lower mortality rate in CKD patients. This relationship has already been observed in the general population. Although this study shows that this association may persist if caffeine is consumed through caffeine-containing soft drinks, the president of the European Renal Nutrition Working Group, Professor Denis Fouque, recommends CKD patients not to consume these soft drinks, but to drink coffee or tea instead.

The dark side of the hottest summer in a century: ‘The high rate of skin cancer among outdoor workers can be expected to increase still further’

[PRESSWIRE] Paris - September 12, 2018 -- The sun is one of the most dangerous carcinogens, yet people who work outdoors are inadequately protected. Since 2014, data on the UV exposure of outdoor workers (such as farmers, road workers, seasonal harvest workers, building workers, roofers, etc.) have been collected in Germany as part of the GENESIS-UV project – with alarming results.

Yorkshire tech firm spearheads new appointment booking service for NHS

[PRESSWIRE] London, United Kingdom - 23 August, 2018 -- Yorkshire tech firm Vapour Cloud has developed a secure, automated appointment booking service for the NHS. 

The Cabin rehab appoints new Chief Clinical Officer

[PRESSWIRE] Thailand - 8/8/2018 -- International behavioral health treatment provider, The Cabin Addiction Services Group recently appointed U.S. healthcare expert Michael Gillis, MSW as its Chief Clinical Officer.

Wellbeing a ‘work in progress’ for most UK HR departments

[PRESSWIRE] London, United Kingdom - 11 June, 2018 -- A study conducted by Cascade has revealed that only 13% of HR/business managers believe their organisation has an effective wellbeing strategy in place. 67% admit that it is ‘a work in progress’.

Shedding a new light: The implication of microRNAs in chronic kidney disease

[PRESSWIRE] Copenhagen, Denmark - 25 May, 2018  -- Development of disease is often related to the deregulation of a gene program controlled at the post-transcriptional level by microRNAs (miRNAs). A new review [1], published in Nephrology Dialysis Transplantation during this week’s ERAEDTA Congress in Copenhagen, shows that miRNAs are potential innovative biomarkers, and are promising as groundbreaking drugs. “The review of Laurent Metzinger and colleagues summarizes the current state of art of the research on miRNAs in kidney disease”, explains Professor Denis Fouque, editor-in-chief of Nephrology, Dialysis, Transplantation (NDT). 

Lanreotide ineffective against familial cystic kidney disease

[PRESSWIRE] Copenhagen, Denmark - 25 May, 2018  --  4-6 million people worldwide are affected by familial cystic kidney disease, the most common inherited kidney disease – accounting for ∼10% of European patients on dialysis or living with a kidney transplant. The range of potential therapies is still limited, so other novel therapy options are urgently needed.